Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Current Oncology (Toronto, Ont.)
|
September 27, 2023
Bevacizumab Treatment for Low-Grade Serous Ovarian Cancer: A Systematic Review
Caitlin Lazurko, Revital Linder, Kate Pulman, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC
|
January 7, 2021
Does Radical Hysterectomy for Clinically Apparent Stage II Endometrial Cancer Affect Risk of Local Recurrence?
Genevieve K Lennox, Mitchell Clark, Tiffany Zigras, et al.
American Journal of Obstetrics and Gynecology
|
July 19, 2025
Association of frailty with healthcare utilization and days alive at home in patients with gynecologic cancers: a population-based study
Julie M V Nguyen, Tiffany Zigras, Anastasia Gayowsky, et al.
Gynecologic Oncology
|
June 8, 2025
Association of frailty with perioperative and survival outcomes in patients with gynecologic cancers: A population-based study
Julie M V Nguyen, Tiffany Zigras, Anastasia Gayowsky, et al.
Current Oncology (Toronto, Ont.)
|
June 27, 2023
Canadian Guideline on the Management of a Positive Human Papillomavirus Test and Guidance for Specific Populations
Tiffany Zigras, Marie-Hélène Mayrand, Celine Bouchard, et al.
Anaerobe
|
May 8, 2022
First reported case of Robinsoniella peoriensis pyometra and bloodstream infection: A case report and review of the literature
Javier Mejia-Gomez, Tiffany Zigras, Yashesh Patel, et al.
Climacteric : the Journal of the International Menopause Society
|
June 8, 2026
The use of menopause hormone therapy in borderline ovarian tumor survivors: a systematic review and meta-analysis
Javier Mejia-Gomez, Melissa Tigert, Michelle Jacobson, et al.
Plos One
|
July 28, 2025
Frailty Assessment for Risk prediction in Gynecologic Oncology patients undergoing surgery and chemotherapy (FARGO) study protocol: Rationale and design of a multi-centre prospective cohort study
Julie My Van Nguyen, Danielle Vicus, Liat Hogen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
February 12, 2015
Dacomitinib (PF-00299804), a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor, demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro
Liancheng Zhu, Salvatore Lopez, Stefania Bellone, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Current Oncology (Toronto, Ont.)
|
September 27, 2023
Bevacizumab Treatment for Low-Grade Serous Ovarian Cancer: A Systematic Review
Caitlin Lazurko, Revital Linder, Kate Pulman, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC
|
January 7, 2021
Does Radical Hysterectomy for Clinically Apparent Stage II Endometrial Cancer Affect Risk of Local Recurrence?
Genevieve K Lennox, Mitchell Clark, Tiffany Zigras, et al.
American Journal of Obstetrics and Gynecology
|
July 19, 2025
Association of frailty with healthcare utilization and days alive at home in patients with gynecologic cancers: a population-based study
Julie M V Nguyen, Tiffany Zigras, Anastasia Gayowsky, et al.
Gynecologic Oncology
|
June 8, 2025
Association of frailty with perioperative and survival outcomes in patients with gynecologic cancers: A population-based study
Julie M V Nguyen, Tiffany Zigras, Anastasia Gayowsky, et al.
Current Oncology (Toronto, Ont.)
|
June 27, 2023
Canadian Guideline on the Management of a Positive Human Papillomavirus Test and Guidance for Specific Populations
Tiffany Zigras, Marie-Hélène Mayrand, Celine Bouchard, et al.
Anaerobe
|
May 8, 2022
First reported case of Robinsoniella peoriensis pyometra and bloodstream infection: A case report and review of the literature
Javier Mejia-Gomez, Tiffany Zigras, Yashesh Patel, et al.
Climacteric : the Journal of the International Menopause Society
|
June 8, 2026
The use of menopause hormone therapy in borderline ovarian tumor survivors: a systematic review and meta-analysis
Javier Mejia-Gomez, Melissa Tigert, Michelle Jacobson, et al.
Plos One
|
July 28, 2025
Frailty Assessment for Risk prediction in Gynecologic Oncology patients undergoing surgery and chemotherapy (FARGO) study protocol: Rationale and design of a multi-centre prospective cohort study
Julie My Van Nguyen, Danielle Vicus, Liat Hogen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
February 12, 2015
Dacomitinib (PF-00299804), a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor, demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro
Liancheng Zhu, Salvatore Lopez, Stefania Bellone, et al.
Page
of 2